Your browser doesn't support javascript.
loading
Enhanced validation of antibodies for research applications.
Edfors, Fredrik; Hober, Andreas; Linderbäck, Klas; Maddalo, Gianluca; Azimi, Alireza; Sivertsson, Åsa; Tegel, Hanna; Hober, Sophia; Szigyarto, Cristina Al-Khalili; Fagerberg, Linn; von Feilitzen, Kalle; Oksvold, Per; Lindskog, Cecilia; Forsström, Björn; Uhlen, Mathias.
Affiliation
  • Edfors F; Science for Life Laboratory, KTH - Royal Institute of Technology, SE-171 21, Stockholm, Sweden.
  • Hober A; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • Linderbäck K; Science for Life Laboratory, KTH - Royal Institute of Technology, SE-171 21, Stockholm, Sweden.
  • Maddalo G; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • Azimi A; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • Sivertsson Å; Science for Life Laboratory, KTH - Royal Institute of Technology, SE-171 21, Stockholm, Sweden.
  • Tegel H; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • Hober S; Department of Oncology-Pathology, Karolinska Institute, Karolinska University Hospital, Stockholm, SE-171 77, Sweden.
  • Szigyarto CA; Science for Life Laboratory, KTH - Royal Institute of Technology, SE-171 21, Stockholm, Sweden.
  • Fagerberg L; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • von Feilitzen K; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • Oksvold P; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • Lindskog C; Science for Life Laboratory, KTH - Royal Institute of Technology, SE-171 21, Stockholm, Sweden.
  • Forsström B; Department of Protein Science, KTH - Royal Institute of Technology, SE-106 91, Stockholm, Sweden.
  • Uhlen M; Science for Life Laboratory, KTH - Royal Institute of Technology, SE-171 21, Stockholm, Sweden.
Nat Commun ; 9(1): 4130, 2018 10 08.
Article in En | MEDLINE | ID: mdl-30297845
ABSTRACT
There is a need for standardized validation methods for antibody specificity and selectivity. Recently, five alternative validation pillars were proposed to explore the specificity of research antibodies using methods with no need for prior knowledge about the protein target. Here, we show that these principles can be used in a streamlined manner for enhanced validation of research antibodies in Western blot applications. More than 6,000 antibodies were validated with at least one of these strategies involving orthogonal methods, genetic knockdown, recombinant expression, independent antibodies, and capture mass spectrometry analysis. The results show a path forward for efforts to validate antibodies in an application-specific manner suitable for both providers and users.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Validation Studies as Topic / High-Throughput Screening Assays / Antibodies / Antibody Specificity Limits: Animals / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2018 Type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Validation Studies as Topic / High-Throughput Screening Assays / Antibodies / Antibody Specificity Limits: Animals / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2018 Type: Article Affiliation country: Sweden